Select a Region

North America

Newscenter

Browsing Archive: RespiratoryRespiratory | EVERSANA

EVERSANA

Posted on 10월 2, 202310/2/23

Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis

EVERSANA

Posted on 10월 2, 202310/2/23

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective

EVERSANA

Posted on 10월 2, 202310/2/23

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England

EVERSANA

Posted on 9월 25, 20239/25/23

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States

EVERSANA

Posted on 2월 1, 20232/1/23

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective

EVERSANA

Posted on 2월 1, 20232/1/23

Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England

EVERSANA

Posted on 10월 2, 202010/2/20

Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis

Respiratory